IFF
53
-3
URI
62
-3
KEY
43
-3
LMT
29
-3
VRSK
54
2
ALLE
44
-4
AVGO
42
12
IP
57
-7
PHM
55
-5
CHRW
42
-5
AES
41
-2
WU
20
-2
TSN
36
-3
DE
46
-3
DOW
40
-2
GM
66
-5
WEC
38
-5
AEP
40
-3
MAS
60
-3
DUK
40
-7
IFF
53
-3
URI
62
-3
KEY
43
-3
LMT
29
-3
VRSK
54
2
ALLE
44
-4
AVGO
42
12
IP
57
-7
PHM
55
-5
CHRW
42
-5
AES
41
-2
WU
20
-2
TSN
36
-3
DE
46
-3
DOW
40
-2
GM
66
-5
WEC
38
-5
AEP
40
-3
MAS
60
-3
DUK
40
-7
Financhill
Back

Keros Therapeutics Stock Predictions

AI DIVIDENDS: No. 1 Way to Collect Passive Income

Click here to get it for free.
Buy
60

KROS
Keros Therapeutics

Last Price:
60.76
Seasonality Move:
38.45%

7 Day Trial

ALL ACCESS PASS

$ 7

Gold Set to Skyrocket as Fed Slashes Rates

Click here for the details on this incredible opportunity.

Keros Therapeutics Stock Forecast

  • Over the next 52 weeks, Keros Therapeutics has on average historically risen by 16.5% based on the past 4 years of stock performance.
  • Keros Therapeutics has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
  • Is Keros Therapeutics Stock Undervalued?
    The current Keros Therapeutics [KROS] share price is $60.14. The Score for KROS is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
  • KROS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Keros Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Keros Therapeutics has on average historically risen by 16.5% based on the past 4 years of stock performance.

Keros Therapeutics Stock Rating

Buy
60
Keros Therapeutics (KROS) is a Buy

Is Keros Therapeutics overpriced?

  • Keros Therapeutics has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%

Keros Therapeutics Stock Price History

Is KROS stock going to rise?

  • The current trend is moderately bullish and KROS is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
kerostx.com

52-Week Data

52-Week High:
73.00
52-Week Low:
27.31

Prediction Charts

Market Cap:
2.26B
Price in USD:
60.14
Volume:
250.37K
Beta:
1.13

Technical Analysis

SMA50:
55.19
SMA100:
51.13
SMA200:
54.89
52-Wk Change:
117.43%

Stock Predictions

  • Is Keros Therapeutics stock public?
    Yes, Keros Therapeutics is a publicly traded company.
  • What is the Keros Therapeutics stock quote today?
    The Keros Therapeutics stock price is 60.14 USD today.
  • How to buy Keros Therapeutics stock online?
    You can buy Keros Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Oct-9 59.67 57.97 59.67 57.87
Oct-10 57.27 57.79 58.05 56.79
Oct-11 57.65 59.78 59.88 56.95
Oct-14 59.38 60.50 61.52 58.71
Oct-15 60.90 60.31 61.40 59.61
Oct-16 61.21 62.18 62.52 59.60
Oct-18 61.28 61.25 61.38 59.99
Oct-21 60.83 60.30 61.22 59.44
Oct-22 59.79 59.33 60.56 58.99
Oct-23 59.09 57.99 60.25 57.95
Oct-24 58.66 59.56 59.87 58.33
Oct-25 60.00 60.76 61.87 59.94
Oct-28 61.52 60.73 62.68 60.73
Oct-29 60.72 60.14 60.72 58.99

Keros Therapeutics Earnings

Keros Therapeutics Earnings Report: Per Share Keros Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Keros Therapeutics Forecast Revenue Growth

Keros Therapeutics Stock Analysis: Historical quarterly revenues per share for Keros Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.28 per share, and a decrease next year of $0.49 per share.

* Keros Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.